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1. Introduction 
The visual cortex is part of the occipital cortex that makes up the primary and secondary 
visual areas [1,2]. In the primary visual areas of rodents, as in other isocortical areas, two 
main neuronal types are present: inhibitory interneurons and projecting neurons [3,4]. The 
inhibitory interneurons belong to several GABAergic subpopulations, while the projection 
neurons are excitatory pyramidal neurons that are classically distributed in 5 layers, each of 
which is associated with a preferential projection area [3,4]. Accordingly, the pyramidal 
neurons of layers II, III and IV give rise to corticocortical connections, while those of layers 
V and VI project to subcortical structures. In the primary visual cortex pyramidal neurons of 
layer V project to superficial collicular layers and they give rise to collaterals that project to 
the pontine nuclei.  
The aim of this review is to describe the sprouting capacities of these projecting neurons and 
to evaluate several strategies to enhance these capabilities in adult animals, principally 
considering work carried out in rodents. In the first part, we will discuss the sprouting of 
the corticocollicular ipsilateral connection in young animals. This connection originates in 
layer V pyramidal neurons and its post-lesional sprouting capacities diminish significantly 
after the end of the critical period (postnatal day 45). We will also discuss the use of siRNAs 
to knockdown the expression of molecules that inhibit post-lesional axonal sprouting in 
adults. Lastly, we will describe alterations in sprouting and synaptic size in the 
corticocortical visual connections. 
2. Differential lesion responses of neonatal and adult visual cortex 
efferents 
The visual system is widely used as a model to study plasticity, given the 
compartmentalized arrangement of its main stations. In rodents, most of the retinal ganglion 
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axons cross the optic chiasm to the contralateral side [5,6]. Thus, retinal deafferentation is a 
convenient experimental means of investigating the plastic response mechanisms to central 
nervous system (CNS) lesions. 
The superior colliculus (SC) is a layered mesencephalic structure that can be divided into 
two main compartments: the superficial strata that are mainly devoted to visual function; 
and the intermediate and deep strata that process multisensorial information [7-9]. The 
superficial layers are composed of the stratum zonale (SZ), stratum griseum superficiale 
(SGS), and stratum opticum (SO), and they receive their main afferent input from the retina 
and primary visual cortex. 
In rats, virtually all retinal ganglion cells project to the contralateral SC [6,10] and the majority 
of optic axons reach the SC prenatally, with the remainder reaching their target in the early 
postnatal days [11]. Layer V pyramidal neurons of the primary visual cortex (VC1) project to 
the ipsilateral SC [12-14], with the first visual cortical axons that reach the SC arriving on 
postnatal day (P) 4/5. At this stage, the axons only appear in the SO. From P7 to P13, these 
projections spread out to the ventral region of the SGS and the intermediate layers, and 
between P13 and P19, connections are restricted to the superficial strata of the SC, ultimately 
forming the organizational pattern seen in adults [15]. Although both retinocollicular and 
corticocollicular terminals densely innervate superficial strata of the SC, the former ramify 
more densely in the SZ and upper SGS, while the latter project to the lower SGS and upper SO 
[12-14]. During development, retinal and primary visual cortex fibers undergo multiple plastic 
changes, which include axonal growth, target path finding, axonal pruning and projection 
refinement [15-17]. This results in the formation of a precisely organized topographic map that 
represents the visual field in the SC in a point-to-point fashion.  
CNS lesions or pathologies, and the deprivation of visual stimuli, can alter the final visual 
corticocollicular organization, predisposing this system to phenomena of neuroplasticity 
[18]. The capacity to respond to CNS lesions through plastic changes varies depending on 
the age at which the injury takes place. Thus, during early postnatal development, while 
connections are being established, neuronal projections exhibit significant capacity for 
regeneration and reorganization in response to neuronal damage. However, this post-
lesional response becomes considerably diminished in adulthood. A remarkable number of 
publications have described changes in the organization of neuronal connections following 
neonatal CNS injury. In the visual system, retinal deafferentation at birth results in severe 
alterations of the afferent systems that project to SC superficial layers [19]. For example, 
removal of SC input in neonatal rodents results in an aberrant ipsilateral retinotectal 
projection [20-24], whereas retinal deafferentation in adults has no such effect [25-27]. 
Gradual, continuous plastic changes have been described in the ipsilateral retinal axons of 
adult rats subjected to contralateral retinal lesions at P21, in contrast to the fast plastic 
response observed in neonatal rats evident within 48 hours of lesion [28]. 
Neonatal lesions of the visual cortex give rise to an aberrant projection to the contralateral 
SC [29] and expansion of the ipsilateral corticocollicular projection from the remaining 
unlesioned visual cortex [30]. These plastic responses during early postnatal development 
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may occur due to axonal sprouting and/or the blockade of developmentally regulated 
axonal retraction. It has been suggested that axons continuously compete for postsynaptic 
sites in the CNS. Indeed, it is likely that during development this competition is essential for 
the formation and refinement of projections, although an equilibrium is reached in the 
mature nervous system that results in the stabilization of neuronal connections [31,32]. 
In previous studies, we observed an enlargement of the visual corticocollicular terminal 
field in rabbits after neonatal removal of contralateral retinal inputs [33], and an alteration in 
the plastic response to injury when the same lesion was performed in adults [34]. The 
anterograde axonal tracer biotin dextran amine (BDA) was used to label the corticocollicular 
connection emerging from layer V pyramidal neurons of the primary visual cortex in 3 
different experimental groups: (i) adult rats (P60) subjected to neonatal (P1) optic nerve 
transection; (ii) adults rats subjected to optic nerve transection in adulthood; and (iii) control 
adults rats. The animals were sacrificed 10 days after BDA injection and the superior 
colliculi extracted for histochemical analysis. As BDA was injected into the region of the 
primary visual cortex that represents the lower temporal visual field [35-36], 
corticocollicular terminal fields were localized within the posterolateral quadrant of the SC 
[37] in all experimental animals. In agreement with previous studies [14,33,38], we observed 
a tight topographical organization of the visual corticocollicular terminal field. In control 
animals, the corticocollicular terminal field was column-shaped, extending from the SO up 
to the pial surface, and it was restricted to a small portion of the collicular surface. Fibers 
ascending from the SO gave rise to dense axonal networks in the lower half of SGS, and they 
branched to reach the upper half of this stratum and the most superficial SZ, where the 
fibers were oriented parallel to the collicular surface [34].  
Visual deprivation in neonatal animals results in significant expansion of the 
corticocollicular visual terminal fields, which invaded the entire lateromedial extension of 
the visual collicular strata. However, the axons tended to concentrate in the posterolateral 
quadrant of the collicular surface, indicating that the gross topography of the connection 
was maintained, despite deafferentation [34]. Molecules involved in target path finding, 
such as ephrins and their receptors, may play a crucial role in determining retinotectal 
topography [39-41]. Neonatal deafferentation also significantly alters the direction of fiber 
projection, resulting in horizontal and oblique orientation in the majority of fibers within the 
SGS in deafferented animals. We previously reported a similar effect in rabbits [33]. 
However, the expansion of this terminal field may reflect the maintenance of collaterals 
during postnatal development [38,42] or active sprouting processes. Previous studies 
reported that in neonatal animals, corticocollicular fibers only appear in the SO [38,43]. As 
we observed a large density of fibers occupying almost the entire extension of the most 
superficial strata, SZ and SO, we can assert that an active process of axonal pruning 
occurred after neonatal deafferentation. 
The labeled visual corticocolicular terminal fields in rats subjected to retinal deafferentation 
in adulthood were columnar, with no changes in extension, although staining was most 
intense in the upper half of the SGS and in the SZ [34]. Anterograde labeling with BDA 
allowed clear morphological identification of presynaptic boutons, and quantification of 
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boutons in the terminal fields revealed a maximal density in the SGS and the SO [34]. 
Similar results were obtained by counting autoradiographic particles following [3H]-leucine 
injection into the primary visual cortex [38]. Despite occurring in neonatal deafferented 
animals, the increase in bouton density in the absence of notable axonal arborization 
suggests that new synaptic terminals are formed and thus, we conclude that adult visual 
corticocollicular afferents maintain a certain degree of plasticity. Comparable synaptogenic 
responses in the adult corticorubral axons have been described following red nucleus 
deafferentation [44]. Cytoskeletal proteins like GAP-43 have been implicated in axonal 
growth [45], and GAP-43 expression in the visual cortex is abundant during postnatal 
development but it decreases in adulthood [46]. These observations may explain the 
differences in axonal branching between deafferented neonates and adults. Indeed, we also 
found that immature vimentin-expressing astrocytes are abundant in the neonatal SC [47], 
where they may induce local sprouting after retinal deafferentation. 
In conclusion, our findings demonstrate that the capacity for post-lesional remodeling is 
partially retained by the adult central nervous system. 
3. Molecular determinants involved in the dampening of the plastic 
response during adulthood 
There is evidence accumulating that glial scar-associated molecules and myelin-derived 
molecules are molecular determinants that contribute to the diminished ability of adult 
neurons to regenerate their axons and reorganize their connections following CNS lesions. 
The glial scar is a meshwork composed of reactive astrocytes, oligodendrocyte precursors, 
meningeal fibroblasts and microglia that migrate to the lesion site to mediate tightly linked 
processes. Not only is it an impenetrable physical barrier to regenerating axons but it is also 
an important source of molecules that directly inhibit regeneration. After neuronal injury, 
reactive astrocytes and meningeal fibroblasts in the glial scar rapidly enhance the 
production and release of extracellular matrix molecules, such as the chondroitin sulfate 
proteoglycans (CSPGs), which are important inhibitors of axonal growth [48-49]. In 
addition, molecules involved in axonal path finding, such as ephrins and ephrin A4 receptor 
[50,51], semaphorin 3A [52-54] and Slit proteins [55], have been implicated in the 
mechanisms by which the gliar scar prevents axonal growth [56]. 
Myelin also mediates the inhibition of axonal growth in the CNS and for 30 years, post-
lesional products of CNS myelin have been known to specifically inhibit axonal extension 
[57]. Subsequent studies confirmed that CNS myelin and mature oligodendrocytes contain 
molecular components that restrict axonal regeneration [58-61]. Several proteins expressed 
by oligodendrocytes have been identified as myelin-associated inhibitors on the basis of 
their ability to inhibit neurite outgrowth and induce growth cone collapse. Of these, Nogo 
[62-64], myelin associated glycoprotein (MAG) [65,66], and oligodendrocyte myelin 
glycoprotein (OMgp) [67] are considered the main contributors to the inhibitory effects of 
CNS myelin. 
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NgR, a GPI-linked protein with multiple leucine-rich repeats, is the receptor for Nogo-66, 
and it mediates the signaling cascade that inhibits axonal growth [68]. More recent studies 
have shown that MAG and OMgp can also bind to NgR to exert their inhibitory actions [69-
71]. The neurotrophin receptor p75 (p75NTR) forms a complex with NgR that mediates axonal 
growth inhibition and that initiates the signaling cascade triggered by myelin derived 
inhibitors [67,71,72]. p75NTR is not ubiquitously expressed in the adult brain, whereas almost 
all mature CNS neurons respond to inhibition by myelin. Thus, it is likely that other 
proteins assume the function of p75NTR. TROY is an orphan member of the tumor necrosis 
factor receptor (TNFR) superfamily that is widely expressed by both embryonic and adult 
neurons [73,74], and it has been identified as a functional homolog of p75NTR that may 
contribute to the inhibitory effects of myelin [75,76]. Nonetheless, the role of TROY as a 
signal transducing receptor in the inhibition of axonal growth remains unclear, as its 
expression has not been consistently demonstrated in the adult CNS [77]. Lingo-1, the third 
component of this receptor complex [78], belongs to a large family of proteins that contain 
leucine-rich repeats and immunoglobulins [79]. Physical association of Lingo-1, NgR and 
p75NTR results in the formation of a tripartite receptor complex that mediates the inhibitory 
signaling triggered by myelin inhibitors [78], and the intracellular signaling cascade this 
complex activates alters the Rac1/RhoA balance in growth cones. RhoA, Rac1 and Cdc42 are 
widely expressed members of the small GTPase family that regulate actin dynamics and 
microtubule assembly. Rac1 and RhoA exert antagonistic effects on growth cone dynamics 
via their effector-kinases, PAK1 and ROCK, stimulating growth cone motility and inducing 
collapse, respectively. In the damaged nervous system, myelin-derived inhibitors alter the 
Rac1 and RhoA signaling equilibrium, augmenting RhoA activity at the expense of Rac1 
activity [80, 81]. RhoA activation activates the sequential ROCK/LIM kinase/cofilin signaling 
cascade, resulting in the depolymerization of actin filaments and subsequent growth cone 
collapse [82]. This intracellular mechanism can be influenced by several molecules, 
including MAG, Nogo, OMgp, Netrin-1, ephrins and CSPGs, and it has been proposed as 
the convergence point of several inhibitors of axonal growth that exert similar functions 
[78,80,83-85]. 
4. Strategies to promote corticocollicular sprouting after visual 
deafferentation in adulthood 
Several strategies have been described to promote the regeneration and reorganization of 
neuronal connections following CNS injury. Regeneration of mature damaged axons has 
been demonstrated using antibodies against myelin-derived inhibitors. For example, 
treatment of adult rats with anti-Nogo-A IN-1 after spinal cord lesions promotes significant 
axonal sprouting and regeneration over long distances caudal to the lesion site, 
accompanied by motor improvements and restoration of sensorial function [86-88]. 
Similarly, in animal models of spinal cord injury and stroke, the intrathecal administration 
of antibodies that effectively neutralize Nogo-A activity enhances regeneration of the 
corticospinal tract fibers, restoring damaged neuronal circuits and promoting functional 
recovery [89,90]. In support of these findings, the intrathecal administration of anti-Nogo-A 
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antibodies in monkeys subjected to cervical spinal cord hemisection promotes extensive 
functional recovery, increased sprouting and regenerative axonal elongation [91].  
Other strategies to promote axonal regeneration and reorganization following adult CNS 
lesions have been described in transgenic animal models. Nogo-A single knockout and 
Nogo-A/B double knockout mice exhibit dramatic increases in axonal sprouting and 
extension after spinal cord injury, accompanied by substantial locomotor recovery [92,93]. 
While no increase in axon regeneration was observed in another study in either Nogo-A/B 
double knockout or Nogo-A/B/C triple knockout mice [94], a more recent study using the 
optic nerve crush model in Nogo-A/B/C triple knockout mice reported significant axon 
regeneration [95], suggesting Nogo influences in axon regeneration in vivo. 
Blockade of RhoA and ROCK activation with C3 transferase and Y-27632 antagonists, 
respectively, enhances axonal growth in myelin substrates in vitro [83,84,96] and in vivo 
[83,84]. However, the effectiveness of these antagonists appears to depend on their mode of 
administration, as C3 transferase was not effective in all in vivo studies [96]. Since the 
discovery of RNA interference [97], numerous studies have focused on inhibiting target 
molecules using siRNAs that specifically silence the expression of target mRNAs [98]. 
Several studies have reported the promotion of neurite outgrowth in vitro following siRNA 
administration. For example, siRNAs against p75NTR disinhibit dorsal root ganglia neurite 
outgrowth in the presence of MAG [99]. Likewise, siRNA-mediated silencing of components 
of the inhibitory signaling cascade, including p75NTR, NgR and RhoA mRNA, enhances 
dorsal root ganglia neurite outgrowth in the presence of CNS myelin, with RhoA 
knockdown exerting the strongest effect [100]. A recent study using a murine model of 
multiple sclerosis demonstrated that systematic administration of siRNAs against Nogo-A 
promotes functional recovery accompanied by a significant increase of GAP43 expression, a 
protein expressed in growing axons. Based on these findings, the authors suggested that 
axonal repair may underlie the improved clinical outcome in mice treated with siRNAs 
against Nogo-A [101]. 
5. Disinhibition of axonal growth by small interfering RNAs against the 
Nogo Receptor and RhoA 
Given the essential role of myelin-derived molecules in the inhibition of neurite outgrowth, 
we studied the effect of NgR and RhoA knockdown, key mediators of the signaling cascade 
that promotes actin depolymerization and subsequent growth cone collapse, and that 
triggers inhibition of axon growth [82]. We investigated whether these interventions result 
in the expansion of the corticocollicular connection in rats subjected to unilateral retinal 
deafferentation in adulthood, a response that normally only occurs when this lesion is 
induced neonatally. To this end, we administered a single injection of siRNAs against NgR 
or RhoA into the left primary visual cortex immediately after the enucleation of the right eye 
in two-month-old Sprague Dawley rats. After four days, the animals received a 
microinjection of the anterograde tracer BDA 10,000 at the site of siRNA administration. 
Seven days later the animals were perfused and the nervous tissue processed for 
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histochemical analysis. Control rats received the same siRNA injections into the primary 
visual cortex. The effect of the siRNAs on NgR and RhoA mRNA levels were measured by 
qRT-PCR in the cortex beneath the injection site. 
Microinjection of siRNAs against NgR and RhoA into the primary visual cortex of adult 
enucleated rats promoted a mild expansion of the ipsilateral visual corticocollicular terminal 
field, although in both cases the centre of the field presented a characteristic column-like 
shape extending from the SO up to the pial surface, a similar pattern to that seen in non-
siRNA treated animals. Likewise, following siRNA injection, many fibers were observed 
running parallel to the pial surface, mainly located within the ventral half of the SGS and 
running away from the terminal field center towards the middle line. Moreover, several 
growth cone-bearing axons were observed in these cases, suggesting active axonal growth 
(Fig. 1, 2). 
To confirm the inhibitory effect of siRNAs on NgR and RhoA mRNA expression in the 
primary visual cortex, and hence the involvement of these molecules in the reorganization 
of the visual corticocollicular field in adult rats subjected to retinal deafferentation, relative 
mRNA levels were quantified by qRT-PCR 24 hours after siRNA injection. This revealed 
significant decreases in NgR and RhoA mRNA levels (44.8 ± 7.3% and 21.67 ± 10.53%, 
respectively, relative to controls: Fig. 3). 
These results demonstrate that siRNA-mediated abolition of the expression of key mediators 
of axonal growth inhibition, such as NgR and more notably RhoA, promotes axonal 
outgrowth after adult CNS injury. Indeed, recent studies using different approaches to 
reduce the expression of molecules involved in axonal growth inhibition have reported 
similar beneficial effects on axonal growth. For example, the administration of monoclonal 
antibodies or peptide antagonists improves axonal and functional regeneration in rats 
subjected to spinal cord lesions [102-104]. An increase in the number of regenerated retinal 
ganglion cells axons passing through and growing beyond the injured optic nerve has also 
been described in an NgR double negative mutant model [105]. Recent studies also 
demonstrated that siRNA knockdown of p75NTR increases dorsal root ganglia neurite 
outgrowth in the presence of MAG [99], while the reduction of NgR expression levels using 
small hairpin RNAs augments axonal growth in neuronal cultures [106]. 
Several authors have reported increased neurite outgrowth following RhoA inactivation, 
both in vitro [80,83,84,96,100,107] and in vivo [83,84]. In our study RhoA knockdown resulted 
in a greater expansion of the visual corticocollicular terminal field. Similarly, siRNA 
knockdown of p75NTR, NgR and most significantly, RhoA, was shown to disinhibit dorsal 
root ganglia neurite outgrowth in the presence of myelin [100]. It was suggested that in 
addition to myelin-derived inhibitory ligands, which act by binding to NgR, other neurite 
growth inhibitors including ephrins, semaphorins and CSPGs, may converge on the RhoA 
signaling pathway leading to growth cone collapse [108,109]. Thus, NgR knockdown may 
block the inhibitory action of myelin derived ligands alone, with no influence on other 
inhibitory ligands. Nonetheless, RhoA knockdown could block the convergent signaling 
from all inhibitory ligands. 
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Figure 1. Scheme showing a dorsal view of the site of BDA injection into the primary visual cortex (left) 
and the projection site in the superior colliculus (right) in different experimental conditions. The 
administration of siRNAs against NgR and RhoA led to the expansion of the visual corticocollicular 
terminal field in animals subjected to retinal deafferentation in adulthood. The black areas in the SC 
denote regions with the greatest density of fibers, while the grey shaded areas denote regions of 
decreasing axonal density. M1VC, monocular primary visual cortex; B1VC, binocular primary visual 
cortex; c, caudal; m, medial; r, rostral. Scale bars = 2 mm (left) and 1 mm (right). 
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Figure 2. Photomicrographs of BDA-labeled visual corticocollicular terminal fields following 
administration of siRNAs against NgR (A,B) and RhoA (C,D) in rats visually deafferented in adulthood. 
(A,C) The microinjection of siRNAs in the primary visual cortex, the projection origin, evoked an 
increase in terminal field extension, with fibers running towards the lateral SC and the medial edge. 
(B,D) Detail of axons in the SGS running away from the terminal field, some exhibiting terminal 
thickening (arrowheads), which may indicate the presence of vestigial growth cone. SGS, stratum 
griseum superficiale; SO, stratum opticum. Scale bars = 100 µm (A,C) and 30 µm (B,D). 
 
 
Figure 3. Relative expression of Nogo Receptor (A) and RhoA (B) mRNA in the primary visual cortex 
following administration of their corresponding siRNAs. Weaker NgR and RhoA mRNA expression in 
the siRNA-treated groups than in the untreated controls was detected. The relative mRNA levels are 
normalized to YWHAZ and TATA box binding protein reference genes. 
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In summary, our in vivo results strongly support the use of siRNAs to silence inhibitors of 
axonal growth, promoting reorganization and axonal outgrowth of the visual 
corticocollicular connection in adult enucleated rats following a single siRNA injection. 
6. Does guanosine enhance corticocortical synaptogenesis? 
Considerable effort has been directed towards identifying the specific molecules that guide 
axonal growth and subsequent synaptogenesis during development, some of which are 
inductive glial factors [110,111]. Evidence gathered over the last decade has attributed a 
fundamental role to astrocytes in regulating synaptogenesis and modulating synaptic 
plasticity during critical periods in different sensory and motor systems [112]. During 
postnatal development, astrocytes are strongly involved in the formation of synaptic 
contacts in the CNS, participating in each of the 3 stages of synaptogenesis: (i) the 
establishment of contacts between neurons; (ii) the formation of the synapse; and (iii) 
synaptic stabilization or elimination [113]. The role of astrocytes in regulating the synaptic 
stability of retinal ganglion cells (RGCs) has been studied in detail by culturing purified 
RGCs in the presence or absence of astrocytes [114]. Astrocytes promote an increase in the 
number of RGC synapses, although this effect is reversible since when cultured for one 
week after removing the glia there is a significant reduction in the number of synaptic 
puncta. The regulatory role of astrocytes in synaptogenesis has also been demonstrated 
through ultrastructural and physiological studies in vivo. Once retinocollicular afferents 
reach the collicular superficial strata, the synaptic arrangement is closely correlated with the 
growth and differentiation of astrocytes at the end of the first postnatal week in rats [114], or 
from P30-P40 in opposums [115]. 
Matricellular proteins are extracellular regulatory factors secreted by astrocytes that mediate 
cell-matrix interactions. This is heterogeneous group of proteins includes thrombospondins 
[116,117], HEVIN [118] and cholesterol [119], which are strongly expressed during 
development and in response to injury [120,121]. In addition, these matricellular proteins 
interact with different matrix constituents, growth factors, integrins and other cell surface 
receptors [122]. Co-culture of purified glutamatergic RGCs with astrocytes results in the 
secretion of cholesterol by glia, which promotes synaptogenesis [122]. The absence of glial 
cells from these cultures, or a reduction in the cholesterol content of glia-conditioned 
medium, diminishes both the number of synapses and GluR2/3 expression by RGCs [123]. 
While cholesterol production within the CNS is necessary for growth and survival, lipid raft 
signaling, synaptic vesicle formation and synaptic function [124], increased synaptogenesis 
and axon pruning requires additional cholesterol production [122]. Recent in vitro studies 
indicate that guanosine increases the efflux of cholesterol from astrocytes [125], the primary 
source of cholesterol in the nervous system. Moreover, binding of cholesterol to 
apolipoprotein E (ApoE) promotes synapse formation in RGC cultures [122]. We assessed 
the synaptogenic effect of guanosine administration in vivo, having anterogradely labeled 
the visual corticocortical connection in young adult male Sprague-Dawley rats by injecting 
BDA into the primary visual cortex. After BDA administration (24 hr), an osmotic pump was 
implanted at the site of BDA injection to administer guanosine (300 M) and 2 weeks after 
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tracer injection, the animals were sacrificed and the nervous tissue analyzed 
histochemically. While a clear corticocortical projection from primary to secondary visual 
areas was observed in all cases, guanosine administration significantly increases the number 
and size of the presynaptic boutons along the axonal branches that reach the secondary 
visual areas, while the pattern of visual corticocortical projections was preserved. Laterally 
running fibers emerged at several different levels, white matter fibers ran close to layer VI, 
while at the level of layers VI and V, afferent fibers gave off divergent branches to form a 
dense plexus. A smaller contingent of corticocortical fibers ran horizontally along layers IV 
and V, and a very superficial group of fibers ran laterally at the level of layer I [126]. 
We observed 2 plexuses in this efferent connection, a deep plexus in layer IV-VI and another 
in the superficial layer I, both of which were connected by ascending fibers that gave off 
scarce divergent branches containing irregularly distributed presynaptic boutons. Treatment 
with guanosine either increased the number or altered the orientation of the axonal branches 
of the visual corticocortical connection. Moreover, the number and size of synaptic boutons 
was significantly higher in these animals, and most were more rounded/oval than those in 
control animals. Guanosine administration significantly increased bouton density 
(number/200 m2), which was 1.3-fold higher in treated versus control rats (p<0.02). 
Moreover, while the average size of small synaptic boutons did not appear to be affected by 
guanosine (0.57 + 0.07 m2 vs. 0.47 + 0.05 m2 in control animals; p<0.002), the larger boutons 
were significantly larger on average in guanosine-treated rats (3.76 + 0.06 m2 vs. 2.26 + 0.1 
m2 in control rats; p<0.002). These data highlight the synaptogenic specificity of the 
astrocytic factors elicited by guanosine (Fig. 4) [126]. 
 
Figure 4. Representative photomicrographs of BDA-labeled visual corticocolicular terminal fields in 
control (A) and guanosine-treated rats (B). Note the markedly higher density of labeled presynaptic 
boutons in the guanosine-treated rat than in the control animals. Scale bar = 20 m. 
We propose that synaptogenesis induced by the local application of guanosine in vivo may 
be mediated by factors such as cholesterol, ApoE and pleiotropic factors secreted by 
astrocytes. Guanosine administration increases both cholesterol and ApoE efflux from 
astrocytes in vitro, supporting a pharmacological role of guanosine in the modulation of 
cholesterol homeostasis in the brain [125]. Moreover, astrocytes that release guanosine can 
exert neurotrophic effects and promote neuritogenesis, possibly via MAP-kinase and PI3-
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kinase signaling pathways [127]. Previous studies failed to report an increase in synapse 
number in response to cholesterol administration in vitro [116], despite a strong 
enhancement in synaptic efficacy [119]. However, guanosine increased both the number or 
size of synaptic boutons in our in vivo model. These morphological changes were observed 
at least one week after 7 days of local guanosine administration and it is likely that this 
effect progressively diminishes over subsequent days, as is usually observed in nervous 
structures following lesion. Nonetheless, the synaptogenic effects promoted by reactive 
astrocytes in denervated terminal fields can last for months [34]. The larger synaptic boutons 
generated following guanosine administration may reflect the accumulation of presynaptic 
components such as mitochondria, synaptic vesicles and presynaptic receptors, elements 
that could eventually exert a modulatory effect upon functional aspects of 
neurotransmission, such as transmitter release or presynaptic potentiation. It remains 
unclear whether the proportion of synapses that contact neurons varies after guanosine 
administration, as astrocytes promote cholesterol-mediated glutamatergic synaptogenesis 
but they induce GABAergic synaptogenesis via a different mechanism [128], raising the 
possibility that the majority of new synapses are glutamatergic. Changes in the proportion 
of inhibitory and excitatory synapses may trigger homeostatic mechanisms [129] that 
maintain the synaptic activity of the connection within certain functional limits. 
Synaptogenesis occurs both during development and adult life. In addition to the 
aforementioned factors, several other factors promote synaptogenesis in mature nervous 
systems, including GDNF (glial derived neurotrophic factor) and sex hormones, particularly 
in areas that display strong synaptic plasticity [130,131]. In vivo studies of the neocortex 
[132,133] revealed the ongoing growth and retraction of dendritic spines, accompanied by 
the elimination and formation of synapses. While we have only examined labeled projecting 
axons, synaptogenic effects may also extend to axons emerging from interneurons. 
Therefore, it may be of interest to analyze GABAergic synaptogenesis in the area 
surrounding the site of implantation of the osmotic pump that supplies guanosine in this 
experimental paradigm. 
The increase in the number and size of a significant proportion of synapses after guanosine 
administration indicates a potentiation of axon growth that may promote reinnervation after 
partial experimental lesion of a neural pathway, or after elimination of a specific afferent 
connection projecting to a given brain region. We are currently investigating other strategies 
to inhibit molecules that restrict axonal sprouting and regeneration, including the injection 
of siRNAs against the p75 receptor and LINGO-1 into the contralateral visual cortex 
following monocular retinal deafferentation, with encouraging preliminary results.  
7. Conclusion 
In contrast to the classical dogma of neuronal regeneration, the results presented here 
indicate that both corticocortical and corticosubcortical connections can be manipulated in 
adult animals. We focused specifically on two connections, namely corticocollicular and 
corticocortical projections emerging from the primary visual cortex, and we demonstrate 
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significant post-lesional sprouting of these neurons following specific siRNA knockdown of 
molecules that inhibit axon regeneration. This strategy is particularly efficacious on a broad 
range of potential targets. The combination of this knockdown approach with strategies to 
promote axonal growth by trophic stimuli may be particularly promising for the therapeutic 
modulation of specific neuronal connections in the future. 
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